News Daily News Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years L.A. McKeown February 13, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2023 Caitlin E. Cox February 01, 2023
News Daily News UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy Michael O'Riordan January 20, 2023
News Daily News Exercise Intensity, Not Volume, Linked to Atherosclerosis Progression in Men Michael O'Riordan January 10, 2023
News Daily News ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly L.A. McKeown December 22, 2022
News Daily News How Lp(a) Levels Compare With LDL-C in FH: Some Surprises Michael O'Riordan November 17, 2022
News Daily News New Risk Models Superior to Pretest Probability at Predicting CAD Yael L. Maxwell November 15, 2022
News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT Michael O'Riordan November 05, 2022
News Daily News New on the Scene Nonstatin Drugs: Experts Provide Guidance Caitlin E. Cox August 31, 2022
News Conference News ESC 2022 ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention Shelley Wood August 27, 2022
News Conference News ESC 2022 First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory L.A. McKeown August 26, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Daily News Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression Michael O'Riordan August 08, 2022
News Daily News Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained Yael L. Maxwell July 15, 2022
News Daily News Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines Michael O'Riordan July 06, 2022
News Conference News EAS 2022 Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively Michael O'Riordan May 27, 2022
News Conference News EAS 2022 Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol Michael O'Riordan May 26, 2022
News Conference News EAS 2022 FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses Michael O'Riordan May 26, 2022